Episode 98: How AI in Medicine is Transforming Arrhythmia Care – Insights from Venture Capital
Can artificial intelligence map your heart and help prevent strokes, dementia, and even death from cardiac arrhythmias?
In this episode, host Elaine Hamm, PhD, talks with Rob Krummen, JD, CEO of Vektor Medical, and Travis Manasco, MD, Principal at Solas BioVentures, about how AI is changing the game for diagnosing and treating heart rhythm disorders. They share how Vektor’s vMap technology — the “Google map of your heart” — pinpoints arrhythmia sources using standard EKGs, fitting seamlessly into existing clinical workflows. The conversation also dives into what investors look for in AI-driven health innovations and how startups can stand out in a crowded field.
In this episode, you’ll learn:
- Why cardiac arrhythmias are more common — and more deadly — than most people realize.
- How vMap’s AI-driven insights can improve outcomes, reduce repeat procedures, and expand care to rural hospitals.
- The key elements investors want to see in AI healthcare pitches, from workflow integration to reimbursement strategy.
If you’re interested in AI in medicine, medtech innovation, or how to pitch to venture capital, this episode delivers valuable lessons straight from the front lines of clinical care and investment.
Links:
Connect with Rob Krummen, JD, and check out Vektor Medical.
Connect with friend of the show Travis Manasco, MD, and check out Solas BioVentures.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with vMap inventor David Krummen, MD, and Solas BioVentures co-founder David Adair, MD, MBA.
Listen to our previous episode with Travis on Crafting a Pitch That Attracts Venture Capital.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU – the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
